Quantitative imaging of the structural changes of osteoarthritis: An exciting challenge for the new millennium Johanne Martel-PelletierJean-Pierre RaynauldJean-Pierre Pelletier Invited Commentary Pages: 465 - 466
What a difference a year makes: Reflections on the ACR recommendations for the medical management of osteoarthritis Marc C. Hochberg OriginalPaper Pages: 473 - 478
Diacerein as a disease-modulating agent in osteoarthritis Géraldine FalgaroneMaxime Dougados OriginalPaper Pages: 479 - 483
Erosive osteoarthritis: Presentation, clinical pearls, and therapy George E. Ehrlich OriginalPaper Pages: 484 - 488
Cell biology of osteoarthritis: The chondrocyte’s response to injury Naoshi FukuiChristopher R. PurpleLinda J. Sandell OriginalPaper Pages: 496 - 505
Joint structure modification in osteoarthritis: Development of SMOAD drugs John F. Beary III OriginalPaper Pages: 506 - 512
Treatment of chronic pain in osteoarthritis: Do opioids have a clinical role? Arthur G. Lipman OriginalPaper Pages: 513 - 519
Clinical evidence for osteoarthritis as an inflammatory disease Theodore Pincus OriginalPaper Pages: 524 - 534
Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis Steven B. AbramsonMukundan AtturRobert Clancy OriginalPaper Pages: 535 - 541